DV
Dividend Vision

PROF Stock — Profound Medical Corp

Profound Medical Corp (PROF)

Updated October 16, 2026.

PROF is a Stock. Total return is -41.0% over the past 10.4 years, 366.8 points behind SPY at 325.8%.

Profound Medical Corp. is a commercial-stage medical device company that develops and markets AI-powered, MRI-guided therapeutic systems for treating prostate disease and other conditions. Its lead product, the TULSA-PRO system, uses robotic transurethral ultrasound and real-time MRI imaging to ablate prostate tissue, while its Sonalleve system applies similar technology to treat uterine fibroids, bone pain, and other benign tumors. The company does not currently distribute to shareholders and is primarily oriented toward growth-focused investors rather than income seekers.

PROF dividend yield and income

Price as of 2026-10-16.

The payment date is 10/16/2019.

PROF performance versus SPY

Price and return data through 2026-10-16.

Total return is -41.0% over the past 10.4 years, 366.8 points behind SPY at 325.8%. Over the past year its total return — price change plus distributions reinvested — is 8.1%. Its deepest 1-year drawdown was 41.5%.

WindowTotal returnCAGR
1M3.1%—
3M-11.4%—
6M-9.2%—
YTD-23.6%—
1Y8.1%—
2Y CAGR—-11.10%
3Y CAGR—-13.60%
5Y CAGR—-16.70%
10Y CAGR—-3.60%
Since inception (10.4 years)-41.0%-5.00%

PROF key facts

Asset type
Stock
Asset class
Equity
Inception date
06/09/2016
Distribution frequency
None
Last close
$6.01 (as of 2026-10-16)
Market cap
$219,607,461
Average volume
130923.0
Payment date
10/16/2019
Beta
0.555
Payout ratio
0.0%
EPS
$-0.99

How Dividend Vision calculates yield and returns

Distribution rate (the posted rate) uses calculation basis unavailable. Issuer rates can use a different denominator and date, including ex-date NAV. Trailing-12-month yield is the sum of split-adjusted cash distributions with ex-dates in the last 12 months, divided by the published price. It lags a recent raise or cut. Total return uses split-adjusted close with distributions reinvested on the ex-dividend date (a modeling convention, not the cash-settlement date) from the first stored bar on or after inception through the latest bar, compared with the same window on the benchmark. That is the security's total return, not your personal gain/loss.

Yield and safety methodology · Distribution rate methodology · Distribution Safety Score methodology

Sources and review

Primary sources: prices and distributions from Dividend Vision, derived from vendor EOD data.

Reviewed by Bert Sweet, CEO and Co-owner of Dividend Vision. Methodology: Distribution Safety Score.

PROF risks and drawbacks

Total return has trailed SPY over the available window. The deepest 1-year drawdown on record here is 41.5%.

Who may consider PROF — and who may not

It is a weaker fit for investors who need monthly cash flow (PROF does not currently distribute); investors whose main goal is matching SPY total return. This is educational context, not a recommendation to buy or sell.

More on PROF

Tagged: Healthcare.

Frequently asked questions

Does PROF pay monthly?

No. PROF does not currently distribute.

When does PROF pay a dividend?

PROF does not currently distribute. The payment date is 10/16/2019.

How has PROF performed?

Total return is -41.0% over the past 10.4 years, 366.8 points behind SPY at 325.8%. Over the past year its total return — price change plus distributions reinvested — is 8.1%. Its deepest 1-year drawdown was 41.5%.

DividendVision analysis is generated from public SEC filing data and may not capture every change. Review the original filing for complete information.